LICENSE AGREEMENTLicense Agreement • November 8th, 2006 • Keryx Biopharmaceuticals Inc • Pharmaceutical preparations
For each subpart H strategy KERYX would also initiate a phase II study. If the FDA accepts a subpart H strategy and an appropriate comparator exists, *****. *****.
ASSIGNMENT AND ASSUMPTION AGREEMENTAssignment and Assumption Agreement • November 8th, 2006 • Keryx Biopharmaceuticals Inc • Pharmaceutical preparations • New York
This ASSIGNMENT AND ASSUMPTION AGREEMENT (the “Assignment”), dated as of October 25, 2006, by and among Keryx Biopharmaceuticals, Inc., a Delaware corporation (the “Assignor”) and AOI Pharmaceuticals, Inc., a Delaware corporation and wholly-owned subsidiary of Assignor (the “Assignee”).
